A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer.
about
Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?Pharmacotherapy for prostate cancer, with emphasis on hormonal treatments.Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer.Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.Formulation strategies for sustained release of proteins.Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation.Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.Strategies of GnRH synthetic analogues determination in doping control: in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameters fluctuations as suitable biomarkers.Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer.In situ-forming PLGA implants loaded with leuprolide acetate/β-cyclodextrin complexes: mathematical modelling and degradation.Applications of Small-Molecule Gels - Drug DeliveryInjectable Polymers
P2860
Q36235541-E09BDC91-BB5C-4A20-8BFA-4F72E3276B58Q36573874-81B93AB6-D3C5-4E12-9C2A-EC76C6191935Q36861017-1E0E0C2F-9A69-4CD7-A328-DCF56765DC19Q36975113-C06CB688-13E1-452D-B742-B45B872446CEQ38027859-76C9642E-6C07-463E-95F6-6DAC65FCB7A2Q38103540-61E45D50-7EE7-441C-AB1D-B5ECA3A08EAFQ38570555-A7F55D90-9F8A-477C-AAA1-BE7BFD9EC4EAQ38640597-C10E106D-4FA6-4F70-B824-4E1128C2C6ADQ39387700-BF00D2E8-685B-42C8-B2D4-011B2289D8F8Q50595028-43FCDC20-99FC-497A-A8CA-41CC77F5F627Q57340601-80649DFF-D602-4332-97D2-C90ADA1CCD0CQ57341085-A2A00E27-A1BA-42BB-AEA5-DA0151B75971
P2860
A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A subcutaneous delivery system ...... treatment of prostate cancer.
@ast
A subcutaneous delivery system ...... treatment of prostate cancer.
@en
type
label
A subcutaneous delivery system ...... treatment of prostate cancer.
@ast
A subcutaneous delivery system ...... treatment of prostate cancer.
@en
prefLabel
A subcutaneous delivery system ...... treatment of prostate cancer.
@ast
A subcutaneous delivery system ...... treatment of prostate cancer.
@en
P2860
P356
P1476
A subcutaneous delivery system ...... treatment of prostate cancer.
@en
P2093
Ramon Perez-Marrero
Robert C Tyler
P2860
P304
P356
10.1517/14656566.5.2.447
P407
P577
2004-02-01T00:00:00Z